New York State Common Retirement Fund Verve Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 21,755 shares of VERV stock, worth $113,561. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,755
Previous 21,755
-0.0%
Holding current value
$113,561
Previous $105,000
17.14%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VERV
# of Institutions
179Shares Held
76.1MCall Options Held
70.3KPut Options Held
194K-
Alphabet Inc. Mountain View, CA12.3MShares$64.5 Million4.92% of portfolio
-
Bvf Inc San Francisco, CA6.9MShares$36 Million1.46% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$34.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$20.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$20.9 Million1.94% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $313M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...